Number Т. 10, № 1-2 (37-38) 2020

Keyword :   skin melanoma

Clinical case of prolonged locoregional progression of malignant skin melanoma
Authors: Ostafiychuk V.V. Korovin S.I. Kukushkina M.M. Tkachenko O.I.... Дата: 2020-04-13 / Review: 16
Immunotherapy in the treatment of melanoma patients: current state of the problem
Authors: Kukushkina M.M. Korovin S.I. Lytvynenko B.V. Т. 8, № 4 (32) 2018 / Review: 1703
The role of immunotherapy in the complex treatment of patients with oral cancer: a view of a clinical oncologist
Author:Korobko Y. Т. 8, № 4 (32) 2018 / Review: 188
Immunotherapy for colorectal cancer: current views and perspectives
Authors: Ponomarova O.V. Ryspayeva D.E. Sivak L.A. Т. 8, № 4 (32) 2018 / Review: 2
Capabilities of immunotherapy of metastasis of melanoma B16 in C57Bl/6 mice with transfer factor
Authors: Fil’chakov F.V. Lоn A.D. Shumilina К.S. Kukushkina S.М.... Т. 8, № 2 (30) 2018 / Review: 212
Immunotherapy is the first line of advanced lung cancer: what is new in 2018
Authors: Ryspayeva D.E. Ponomarova O.V. Lisovska N.Y. Т. 8, № 2 (30) 2018 / Review: 1
Immunotherapy of Hodgkin’s lymphoma: a new treatment strategy
Author:Kriachok I.A. Т. 8, № 2 (30) 2018 / Review: 3450
Molecular and genetic markers of tumor stem cells
Author:Grinevich Yu.A. №3(27) 2017 / Review: 493
Breast cancer immunotherapy: importance, prospects, problems
Authors: Sivak L.A. Verevkina N.O. №2(26) 2017 / Review: 1295
Low-dose cyclophosphamide in the treatment of patients with lymphogenous metastases of melanoma
Authors: Korovin S.I. Ostafiychuk V.V. Kukushkina M.M. Palivets A.... №2(26) 2017 / Review: 648
 Immunoreactivity in melanoma patients: the relationship with morphological signs of primary tumor ulceration and long-term results of combined treatment
Authors: Kukushkina S.М. Fil’chakov F.V. Korovin S.I. Grabovyi A.N.... №1(25) 2017 / Review: 394
Immunotherapy of advanced melanoma
Authors: Kukushkina M.M. Korovin S.I. Kukushkina S.М. Palivets A.... №1(25) 2017 / Review: 2098
Modern approaches to the treatment of inoperable non-small cell lung cancer
Authors: Klimаnоv М.Yu. Sivak L.A. Tarasenko T. Askоlskiy А.В.... №4(24) 2016 / Review: 2539
Innovative breakthrough in cancer immunotherapy: pembrolizumab opportunities
Author:Maltsev D.V. №4(24) 2016 / Review: 1
Development trends of immune therapy in oncology. Review of researches, carried out in National Cancer Institute
Author:Grinevich Yu.A. №1(21) 2016 / Review: 4279

12